Royal Bank Of Canada (RY) Stock Price Declined While Toronto Dominion Bank Increased Holding

July 13, 2018 - By Sheila Anderson

Toronto Dominion Bank increased its stake in Royal Bank Of Canada (RY) by 1392.53% based on its latest 2018Q1 regulatory filing with the SEC. Toronto Dominion Bank bought 11.70 million shares as the company’s stock declined 6.00% with the market. The institutional investor held 12.54M shares of the commercial banks company at the end of 2018Q1, valued at $967.85M, up from 840,200 at the end of the previous reported quarter. Toronto Dominion Bank who had been investing in Royal Bank Of Canada for a number of months, seems to be bullish on the $112.31B market cap company. The stock decreased 0.12% or $0.09 during the last trading session, reaching $77.04. About 263,576 shares traded. Royal Bank of Canada (NYSE:RY) has risen 9.18% since July 13, 2017 and is uptrending. It has underperformed by 3.39% the S&P500.

Toronto Dominion Bank, which manages about $44.90 billion US Long portfolio, decreased its stake in Athenahealth Inc (NASDAQ:ATHN) by 100,200 shares to 204,800 shares, valued at $29.29M in 2018Q1, according to the filing. It also reduced its holding in Mednax Inc (NYSE:MD) by 183,600 shares in the quarter, leaving it with 287,900 shares, and cut its stake in Eastman Chemical Company (NYSE:EMN).

More important recent Royal Bank of Canada (NYSE:RY) news were published by: Fool.ca which released: “5 Small-Cap Conviction Stocks to Buy Now” on July 11, 2018, also Seekingalpha.com published article titled: “Royal Bank Of Canada: I Still Remain Optimistic”, Bizjournals.com published: “San Francisco fintech that cashes in home equity raises $40 million from global banks” on June 26, 2018. More interesting news about Royal Bank of Canada (NYSE:RY) was released by: Seekingalpha.com and their article: “Federal Reserve objects to Deutsche Bank USA’s capital return plan” with publication date: June 28, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.